iHuman Inc. (IH) shareholders
IHNYSEServices-Educational ServicesFiscal year ends December 31
$0.99−0.02 (-1.98%)
Close on Nov 13, 2026Market cap $101.20MP/E 3.7Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 511M shares
Institutional holders
8
2 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 38,000 | 0.01% | $53.22K | −16,200 | 0.00% |
| Citadel Advisors LLC | 32,689 | 0.01% | $45.78K | +7,661 | 0.00% |
| Susquehanna International Group, Llp | 16,945 | 0.00% | $23.73K | +6,733 | 0.00% |
| Acadian Asset Management LLC | 15,067 | 0.00% | $20.00K | – | 0.00% |
| Goldman Sachs Group Inc | 12,626 | 0.00% | $17.68K | New | 0.00% |
| Credit Agricole S A | 10,000 | 0.00% | $14.01K | New | 0.00% |
| Bnp Paribas Arbitrage, Snc | 4,200 | 0.00% | $5.88K | – | 0.00% |
| UBS Group AG | 129 | 0.00% | $181 | +30 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 0.0% | 2 / 3 | 1 / 1 | 0M | 0M |
| Q1 2026 | 7 | 0M | 0.0% | 0 / 2 | 4 / 2 | 0M | 0M |
| Q4 2025 | 9 | 0M | 0.0% | 2 / 3 | 3 / 0 | 0M | 0M |
| Q3 2025 | 7 | 0M | 0.0% | 0 / 1 | 3 / 2 | 0M | 0M |
| Q2 2025 | 9 | 0M | 0.0% | 2 / 1 | 4 / 2 | 0M | 0M |
| Q1 2025 | 10 | 0M | 0.0% | 4 / 3 | 2 / 0 | 0M | 0M |
| Q4 2024 | 6 | 0M | 0.0% | 1 / 2 | 1 / 1 | 0M | 0M |
| Q3 2024 | 6 | 0M | 0.0% | 2 / 1 | 1 / 4 | 0M | 1M |
| Q2 2024 | 8 | 1M | 0.3% | 2 / 2 | 2 / 1 | 0M | 1M |
| Q1 2024 | 7 | 2M | 0.4% | 3 / 1 | 1 / 0 | 0M | 1M |
| Q4 2023 | 4 | 3M | 0.5% | 0 / 2 | 0 / 4 | 0M | 0M |
| Q3 2023 | 8 | 3M | 0.5% | 2 / 4 | 1 / 1 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Weiwei Wang | Chief Financial Officer, Director | 200,000 | 0.04% | Mar 18, 2026 |
| Peng Dai | Chief Executive Officer, Director | 16,000,000 | 3.13% | Mar 18, 2026 |
| Congyu Lin | Chief Strategy Officer | 8,000 | 0.00% | Jul 9, 2026 |
| Teng Li | Co-Chief Executive Officer | – | – | Jul 9, 2026 |
| Wenbin Lu | Chief Technology Officer | 8,000,000 | 1.57% | Mar 18, 2026 |
| Xuenan Li | Director | – | – | Mar 18, 2026 |
| Yufeng Chi | Director | 144,000,000 | 28.18% | Mar 18, 2026 |
| Hanfeng Chi | Director | – | – | Mar 18, 2026 |
| Wendy W. Hayes | Director | – | – | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 20 days
16.8%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of iHuman's stock actually held short. Settlement fails (shares not delivered on time) peaked at 44 shares on Sep 18, 2026 over the last 90 days.
See a number that looks wrong?